Amgen Inc (AMGN)
Pretax margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) | US$ in thousands | 4,609,000 | 7,855,000 | 7,346,000 | 6,701,000 | 8,133,000 |
| Revenue | US$ in thousands | 33,424,000 | 28,190,000 | 26,323,000 | 25,979,000 | 25,424,000 |
| Pretax margin | 13.79% | 27.86% | 27.91% | 25.79% | 31.99% |
December 31, 2024 calculation
Pretax margin = EBT ÷ Revenue
= $4,609,000K ÷ $33,424,000K
= 13.79%
Amgen Inc's pretax margin has shown some fluctuations over the past five years. Starting at a high of 31.99% in December 2020, the pretax margin decreased to 25.79% by December 2021. There was a slight recovery in December 2022 and 2023, with margins of 27.91% and 27.86% respectively. However, there was a significant decline in December 2024, with the pretax margin falling to 13.79%. This downward trend in pretax margin in recent years may indicate potential challenges in controlling operating expenses or generating sufficient revenue to cover costs before taxes. It would be important for stakeholders to monitor this trend closely to understand the factors driving these changes and evaluate the company's financial performance and efficiency.
Peer comparison
Dec 31, 2024